Astrazeneca Pharma India Ltd EPS

Astrazeneca Pharma India Ltd EPS

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

EPS

₹ 76.57

Last updated on: Jun 11, 2026

Key Highlights

  • The Earning per Share of Astrazeneca Pharma India Ltd is ₹ 76.57 as of 11 Jun 26 The earning per share of Astrazeneca Pharma India Ltd changed from ₹ -4.72 to ₹ 17.95 over 8 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Astrazeneca Pharma India Ltd

No data available

* All values are in

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

20,622 Cr

EPS

76.6

P/E Ratio (TTM)

108.4

P/B Ratio (TTM)

23.8

Day’s High

8402.0

Day’s Low

8168.6

DTE

0.1

ROE

21.5

52 Week High

10653.05

52 Week Low

7630.0

ROCE

25.5

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Jun 20268248.8
10 Jun 20268304.35
09 Jun 20268457.45
08 Jun 20268383.4
05 Jun 20268598.6
04 Jun 20268497.05
03 Jun 20268548.3
02 Jun 20268719.05
01 Jun 20268724.25
29 May 20268671.45

BlinkX Score for Astrazeneca Pharma India Ltd

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

20,761

Asset Value

Value addition

13.9 X

1,393

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Astrazeneca Pharma India Ltd20760
Sun Pharmaceutical Industries Ltd428785
Divis Laboratories Ltd176242
Torrent Pharmaceuticals Ltd151058
Cipla Ltd111180
Zydus Lifesciences Ltd110474

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Astrazeneca Pharma India Ltd News Hub

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30

Read more

08 Aug 24

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag

Read more

08 Aug 24

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI

Read more

24 Sept 24

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini

Read more

24 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Astrazeneca Pharma India Ltd

What is the EPS of Astrazeneca Pharma India Ltd stock?

The Earnings Per Share (EPS) of Astrazeneca Pharma India Ltd is 76.57. An EPS is the amount of net income attributed to each share of a common stock.

How is Astrazeneca Pharma India Ltd EPS calculated?

The EPS of Astrazeneca Pharma India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Astrazeneca Pharma India Ltd report its EPS?

Astrazeneca Pharma India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Astrazeneca Pharma India Ltd EPS?

Factors that influence the EPS of Astrazeneca Pharma India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Astrazeneca Pharma India Ltd EPS growth indicate future performance?

Yes, consistent growth in Astrazeneca Pharma India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions